Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in Mice
Top Cited Papers
- 9 March 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 121 (9), 1113-1123
- https://doi.org/10.1161/circulationaha.109.898312
Abstract
Background— Aging and aging-related disorders impair the survival and differentiation potential of bone marrow mesenchymal stem cells (MSCs) and limit their therapeutic efficacy. Induced pluripotent stem cells (iPSCs) may provide an alternative source of functional MSCs for tissue repair. This study aimed to generate and characterize human iPSC-derived MSCs and to investigate their biological function for the treatment of limb ischemia. Methods and Results— Human iPSCs were induced to MSC differentiation with a clinically compliant protocol. Three monoclonal, karyotypically stable, and functional MSC-like cultures were successfully isolated using a combination of CD24 − and CD105 + sorting. They did not express pluripotent-associated markers but displayed MSC surface antigens and differentiated into adipocytes, osteocytes, and chondrocytes. Transplanting iPSC-MSCs into mice significantly attenuated severe hind-limb ischemia and promoted vascular and muscle regeneration. The benefits of iPSC-MSCs on limb ischemia were superior to those of adult bone marrow MSCs. The greater potential of iPSC-MSCs may be attributable to their superior survival and engraftment after transplantation to induce vascular and muscle regeneration via direct de novo differentiation and paracrine mechanisms. Conclusions— Functional MSCs can be clonally generated, beginning at a single-cell level, from human iPSCs. Patient-specific iPSC-MSCs can be prepared as an “off-the-shelf” format for the treatment of tissue ischemia.This publication has 26 references indexed in Scilit:
- Aging Adversely Impacts Biological Properties of Human Bone Marrow‐derived Mesenchymal Stem Cells: Implications for Tissue Engineering Heart Valve ConstructionArtificial Organs, 2010
- Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor CellsPLOS ONE, 2009
- Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cellsBMC Cell Biology, 2008
- Self-renewal and differentiation capacity of young and aged stem cellsExperimental Cell Research, 2008
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCsThe International Journal of Cell Cloning, 2006
- Successful Stem Cell Therapy Using Umbilical Cord Blood-Derived Multipotent Stem Cells for Buerger's Disease and Ischemic Limb Disease Animal ModelThe International Journal of Cell Cloning, 2006
- Mesenchymal Stem Cells and the Treatment of Cardiac DiseaseExperimental Biology and Medicine, 2006
- Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart DiseaseCirculation, 2004